ML-162 |
Katalog-Nr.GC44214 |
ML-162 ist ein kovalenter Glutathionperoxidase 4 (GPX4)-Inhibitor. ML-162 hat eine selektive tödliche Wirkung auf mutierte RAS-Onkogen-exprimierende Zelllinien
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1035072-16-2
Sample solution is provided at 25 µL, 10mM.
ML-162 is a GPX4 inhibitor that is selectively lethal to mutant RAS oncogene-expressing cell lines (IC50s = 25 and 578 nM for HRASG12V-expressing and wild-type BJ fibroblasts, respectively).[1],[2] It shares a similar structure but is more potent and selective than (1S,3R)-RSL3, a previously reported inhibitor of RAS oncogene-expressing cells.[2]
Reference:
[1]. Yang, W.S., and Stockwell, B.R. Ferroptosis: Death by lipid peroxidation. Trends Cell Biol. 26(3), 165-176 (2016).
[2]. Weïwer, M., Bittker, J.A., Lewis, T.A., et al. Development of small-molecule probes that selectively kill cells induced to express mutant RAS. Bioorg. Med. Chem. Lett. 22(4), 1822-1826 (2012).
Average Rating: 5
(Based on Reviews and 19 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *